Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?
Author(s) -
Cosimo Durante,
Teresa Montesano,
Marco Attard,
Massimo Torlontano,
Fabio Monzani,
Giuseppe Costante,
Domenico Meringolo,
M Ferdeghini,
Dario Tumino,
Livia Lamartina,
Alessandro Paciaroni,
Michela Massa,
Luciano Giacomelli,
Giuseppe Ronga,
Sébastiano Filetti
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1123
Subject(s) - medicine , thyroglobulin , immunoradiometric assay , thyroidectomy , thyroid cancer , ablation , thyroid , gastroenterology , papillary thyroid cancer , urology , endocrinology , surgery , radioimmunoassay
Serum thyroglobulin (Tg) assays are considered fundamental in postoperative surveillance of differentiated thyroid cancer (DTC) patients. However, the postsurgical profile of Tg levels has never been specifically investigated in patients who do not undergo radioiodine remnant ablation (RRA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom